Last reviewed · How we verify
Mass treatment with oral azithromycin to an entire community — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Mass treatment with oral azithromycin to an entire community (Mass treatment with oral azithromycin to an entire community) — University of California, San Francisco.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mass treatment with oral azithromycin to an entire community TARGET | Mass treatment with oral azithromycin to an entire community | University of California, San Francisco | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mass treatment with oral azithromycin to an entire community CI watch — RSS
- Mass treatment with oral azithromycin to an entire community CI watch — Atom
- Mass treatment with oral azithromycin to an entire community CI watch — JSON
- Mass treatment with oral azithromycin to an entire community alone — RSS
Cite this brief
Drug Landscape (2026). Mass treatment with oral azithromycin to an entire community — Competitive Intelligence Brief. https://druglandscape.com/ci/mass-treatment-with-oral-azithromycin-to-an-entire-community. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab